Eldelumab

Tax included
Eldelumab (BMS-936557) is a humanised anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease.
MedChemExpress 
HY-P99190

Data sheet

Size
Multiple sizes
Reactivity
CXCR
Application
COVID-19-immunoregulation
CAS
946414-98-8